High Energy Formula Feeding in Infants With Congenital Heart Disease
Sponsor: Dr. Sami Ulus Children's Hospital
This NA trial investigates Growth Failure and Neurodevelopmental Disorder and is currently ongoing. Dr. Sami Ulus Children's Hospital leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Study Description(click to expand)Infants with congenital heart disease (CHD) usually show growth retardation as they can not intake enough calorie due to fluid restriction. We hypothesize that high energy formula more positively affect growth in infants with congenital heart disease compared to standard formula
Infants with congenital heart disease (CHD) usually show growth retardation as they can not intake enough calorie due to fluid restriction. We hypothesize that high energy formula more positively affect growth in infants with congenital heart disease compared to standard formula
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dr. Sami Ulus Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .